Table 1 Study participant/sample characteristics
Evaluation 1 | Evaluation 2 | |
|---|---|---|
Sample size (N) | 494 | 539 |
Age, years (median, IQR) | 34, 24–47 | 36, 24–50 |
Gender (%, n/N female) | 57.29, 283/494 | 51.76, 279/539 |
% positivity (n/N) | 31.00, 153/494 | 13.17 (71/539) |
Presence of symptoms | ||
Asymptomatic/presymptomatic (%, n/N) | 33.33, 129/387 | 29.50, 159/539 |
< 7-day PSO (%, n/N) | 57.36, 222/387 | 64.01, 345/539 |
= > 7-day PSO (%, n/N) | 9.30, 36/387 | 6.49, 35/539 |
HIV positive (%, n/N)# | 0.42, 2/481 | 0.20, 1/539 |
CN value (median, IQR) | 9.06, 5.90–16.90 | 15.08, 11.53–23.86 |
Oxygen saturation (median, IQR) | 96, 95–98 | 96, 95–97 |